Highlights
NASDAQ: BGNE       Beigene Ltd ADR
Last Price Today's Change   Day's Range   Trading Volume
212.93   +10.03 (4.94%)  194.50 - 212.94  428,500

Overview

 
Avg Volume (4 weeks):280,202
4 Weeks Range:194.50 - 275.72
4 Weeks Price Volatility (%):
22.69%
52 Weeks Range:194.50 - 426.56
52 Weeks Price Volatility (%):
7.94%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

BeiGene Ltd is a United States based clinical-stage biopharmaceutical company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

7588  2744  952  641 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AAPL 170.33+11.11 
 TQQQ 56.37+4.81 
 SPY 441.95+10.71 
 UVXY 16.95-1.70 
 QQQ 351.80+10.70 
 IMPP 2.18+1.02 
 VXX 22.95-1.54 
 AMD 105.24+2.64 
 NIO 20.90-0.21 
 F 19.54+0.09